Cite
MLA Citation
Giacomo Bregni et al.. “Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.” Acta oncologica, vol. 60, 2021, pp. 549–553. http://access.bl.uk/ark:/81055/vdc_100127474710.0x000052